Verrica Pharmaceuticals Inc. (VRCA) Earnings Per Share (EPS)
Verrica Pharmaceuticals Inc. (VRCA) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$17.10 |
| 2021-12-31 | -$13.00 |
| 2022-12-31 | -$7.20 |
| 2023-12-31 | -$14.80 |
| 2024-12-31 | -$14.80 |
| 2025-12-31 | -$1.68 |
How VRCA compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
| OCUL | Ocular Therapeutix Inc. | -$1.42 |
| NTRA | Natera Inc. | -$1.52 |
| HSDT | Helius Medical Technologies Inc. | -$1.85 |
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
These are five companies in the same sector as VRCA with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Verrica Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("VRCA")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRCA | $4.78 | -2.65% | 0.04M |
| 3 | ||||
| 4 | ||||
| 5 |